The role of N-acetylation polymorphisms in smoking-associated bladder cancer: Evidence of a gene-gene-exposure three-way interaction

Cancer Research

Volumn 58, Issue 16, 1998, Pages 3603-3610

  Taylor, Jack A ^a   Umbach, David M ^a   Stephens, Elizabeth ^a   Castranio, Trisha ^a   Paulson, David ^b   Robertson, Cary ^b   Mohler, James L ^c   Bell, Douglas A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC AMINE; CARCINOGEN; DNA; TOBACCO SMOKE;

ACETYLATION; ADULT; AGED; ALLELE; ARTICLE; BLADDER CANCER; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; GENE; GENE DOSAGE; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; METABOLISM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING;

ACETYLATION; ACETYLTRANSFERASES; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ALLELES; ARYLAMINE N-ACETYLTRANSFERASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; ISOENZYMES; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OCCUPATIONS; POLYMORPHISM, GENETIC; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 0032529236     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer Statistics, 1996. CA Cancer J. Clin., 46: 5-27, 1996.
2. Vineis, P. Epidemiology of cancer from exposure to arylamines. Environ. Health Perspect., 102: 7-10, 1994.
3. Patrianakos, C., and Hoffmann, D. Chemical studies of tobacco smoke. 64. On the analysis of aromatic amines in cigarette smoke. J. Anal. Chem., 3: 150-154, 1979.
4. Landi, M. T., Zocchetti, C., Bernucci, I., Kadlubar, F. F., Tannenbaum, S., Skipper, P., Bartsch, H., Malaveille, C., Shields, P., Caporaso, N. E., and Vineis, P. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels. Cancer Epidemiol. Biomark. Prev., 5: 693-698, 1996.
5. Kadlubar, F. F., and Badawi, A. F. Genetic susceptibility and carcinogen-DNA adduct formation in human urinary bladder carcinogenesis. Toxicol. Lett., 82: 627-632, 1995.
6. Vineis, P., Bartsch, H., Caporaso, N., Harrington, A. M., Kadlubar, F. F., Landi, M. T., Malaveille, C., Shields, P. G., Skipper, P., Talaska, G., and Tannenbaum, S. R. Genetically based n-acetyltransferase metabolic polymorphism and low level environmental exposure to carcinogens. Nature (Lond.), 369: 154-156, 1994.
7. Bell, D. A., Taylor, J. A., Butler, M. A., Stephens, E. A., Wiest, J., Brubaker, L. H., Kadlubar, F. F., and Lucier, G. W. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis (Lond.), 14: 1689-1692, 1993.
8. Hughes, N., McQueen, K., Janezic, S., Jewett, M., Castranio, T., Bell, D. A., and Grant, D. M. Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective functions using p-aminosalicylate as an in vivo/in vitro probe. Pharmacogenetics, 8: 55-66, 1997.
9. Vatsis, K. P., and Weber, W. W. Structural heterogeneity of Caucasian N-acetyltransferase at the NAT1 gene locus. Arch. Biochem. Biophys., 301: 71-76, 1993.
10. Bell, D. A., Badawi, A. F., Lang, N. P., Ilett, K. F., Kadlubar, F. F., and Hirvonen, A. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res., 55: 5226-5229, 1995.
11. Kirlin, W. G., Trinidad, A., Yerokun, T., Ogolla, F., Ferguson, R. J., Andrews, A. F., Brady, P. K., and Hein, D. W. Polymorphic expression of acetyl coenzyme A-dependent 0-acetyltransferase-mediated activation of N-hydroxyarylamines by human bladder cytosols. Cancer Res., 49: 2448-2454, 1989.
12. Frederickson, S. M., Messing, E. M., Resnikoff, C. A., and Swaminathan, S. Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells. Cancer Epidemiol. Biomark. Prev., 3: 25-32, 1994.
13. Badawi, A. F., Hirvonen, A., Bell, D. A., Lang, N. P., and Kadlubar, F. F. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res., 55: 5230-5237, 1995.
14. Bell, D. A., Taylor, J. A., Paulson, D. F., Robertson, C. N., Mohler, J. L., and Lucier, G. W. A common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst., 83: 1159-1164, 1993.
15. Bell, D. A., Stephens, E. A., Castranio, T., Umbach, D. M., Watson, M., Deakin, M., Elder, J., Hendrickse, C., Duncan, H., and Strange, R. C. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res., 55: 3537-3542, 1995.
16. Lin, H. J., Probst-Hensch, N., Hughes, N., Sakamoto, G. T., Louie, A. D., Kau, I., Zhou, H., Lin, B. K., Lee, D., Lin, J., Frankl, H. D., Lee, E. R., Hardy, S., Grant, D. M., and Haile, R. W. Monomorphic N-acetyltransferase NAT1: genetic variants and a case-control study of colorectal adenomas. Pharmacogenetics, 8: 269-281, 1998.
17. Kleinbaum, D. G., Kupper, L. L., and Morgenstern, H. Epidemiologic Research Principles and Quantitative Methods. New York: Van Nostrand Reinhold, 1982.
18. Risch, A., Wallace, D. M. A., Bathers, S., and Sim, E. Slow n-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum. Mol. Genet., 4: 231-236, 1995.
19. Brockmoller, J., Cascorbi, I., Kerb, R., and Roots, I. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res., 56: 3915-3925, 1996.
20. Okkels, H., Sigsgaard, T., Wolf, H., and Autrup, H. Arylamine N-acetyltransferase 1 (NAT1), and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking. Cancer Epidemiol. Biomark. Prev., 6: 225-231, 1997.
21. Cartwright, R. A., Glashan, R. W., Rogers, H. J., Ahmad, R. A., Barham-Hall, D., Higgins, E., and Kahn, M. A. Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet, 2: 842-845, 1982.
22. Hanke, J., and Krajewska, B. Acetylation phenotype and bladder cancer. J. Occup. Med., 32: 917-918, 1990.
23. Lewalter, J., and Miksche, L. Individual variation and immunological effects in human biomonitoring. In: R. C. Garner, P. B. Farmer, G. T. Steel, and A. S. Wright (eds.), Human Carcinogen Exposure, Biomonitoring and Risk Assessment, pp. 315-327. Oxford, United Kingdom: Oxford University Press, 1991.
24. Weber, W. W., Mattano, S. S., and Levy, G. N. Acetylation pharmacogenetics and aromatic amine-induced cancer. In: C. M. King, L. J. Romano, and D. Schuetzle (eds.), Carcinogenic and Mutagenic Responses to Aromatic Amines and Nitroarenes, pp. 115-123, New York: Elsevier Science Publishing Co., Inc., 1988.
25. Hayes, R. B., Bi, W., Rothman, N., Broly, F., Caporaso, N., Feng, P., You, X., Yin, S., Woosley, R. L., and Meyer, U. A. N-Acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers. Carcinogenesis (Lond.), 14: 675-678, 1993.
26. Lakshmi, V. M., Bell, D. A., Watson, M. A., Zenser, T. V., and Davis, B. B. N-Acetylbenzidine and N,N′-diacetylbenzidine. formation by rat and human liver slices exposed to benzidine. Carcinogenesis (Lond.), 16: 1565-1571, 1995.
27. Rothman, N., Bhatnagar, V. K., Hayes, R. B., Zenser, T. V., Kashyap, S. K., Butler, M. A., Bell, D. A., Lakshmi, V., Jaeger, M., Kashyap, R., Hirvonen, A., Schulte, P. A., Dosemeci, M., Hsu, F., Parikh, D. J., Davis, B. B., and Talaska, G. The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers. Proc. Natl. Acad. Sci. USA, 93: 5084-5089, 1996.
28. Rothman, N., Talaska, G., Hayes, R. B., Bhatnagar, V. K., Bell, D. A., Lakshmi, V., Kashyap, S. K., Kashyap, R., Hsu, F., Jaeger, M., Hirvonen, A., Dosemeci, M., Parikh, D. J., Davis, B., and Zenzer, T. V. Acidic urine pH is associated with elevated levels of free urinary benzidine and N-acetylbenzidine and exfoliated urothelial cell DNA adducts in exposed workers. Cancer Epidemiol. Biomark. Prev., 6: 1039-1042, 1997.
29. Hein, D. W., Doll, M. A., Rustan, T. D., Gray, K., Feng, Y., Ferguson, R. J., and Grant, D. M. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and NAT2 acetyltransferases. Carcinogenesis (Lond.), 14: 1633-1638, 1993.